1. Home
  2. OMER vs SWIM Comparison

OMER vs SWIM Comparison

Compare OMER & SWIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omeros Corporation

OMER

Omeros Corporation

N/A

Current Price

$13.29

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Logo Latham Group Inc.

SWIM

Latham Group Inc.

N/A

Current Price

$7.89

Market Cap

963.2M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
OMER
SWIM
Founded
1994
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Plastic Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
963.2M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
OMER
SWIM
Price
$13.29
$7.89
Analyst Decision
Buy
Hold
Analyst Count
3
7
Target Price
★ $27.50
$8.80
AVG Volume (30 Days)
★ 1.2M
966.1K
Earning Date
11-16-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
98.15
★ 160.00
EPS
0.13
★ 0.14
Revenue
$29,868,000.00
★ $545,912,000.00
Revenue This Year
N/A
$11.61
Revenue Next Year
$66.13
$5.92
P/E Ratio
$107.77
★ $56.96
Revenue Growth
N/A
★ 7.35
52 Week Low
$6.70
$4.64
52 Week High
$21.24
$8.97

Technical Indicators

Market Signals
Indicator
OMER
SWIM
Relative Strength Index (RSI) 30.78 57.62
Support Level $9.45 $5.85
Resistance Level $19.68 $8.51
Average True Range (ATR) 0.92 0.37
MACD -0.45 -0.05
Stochastic Oscillator 8.90 52.17

Price Performance

Historical Comparison
OMER
SWIM

About OMER Omeros Corporation

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

About SWIM Latham Group Inc.

Latham Group Inc is a designer, manufacturer, and marketer of in-ground residential swimming pools, liners, and covers in North America, Australia, and New Zealand. The company derives a majority of its revenue from the United States.

Share on Social Networks: